A detailed history of State Of Tennessee, Treasury Department transactions in Pfizer Inc stock. As of the latest transaction made, State Of Tennessee, Treasury Department holds 2,230,552 shares of PFE stock, worth $58.4 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
2,230,552
Previous 2,095,646 6.44%
Holding current value
$58.4 Million
Previous $58.6 Million 10.09%
% of portfolio
0.23%
Previous 0.22%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$27.7 - $31.39 $3.74 Million - $4.23 Million
134,906 Added 6.44%
2,230,552 $64.6 Million
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $943,738 - $1.11 Million
-37,361 Reduced 1.75%
2,095,646 $58.6 Million
Q1 2024

May 14, 2024

SELL
$25.89 - $29.73 $1.87 Million - $2.14 Million
-72,043 Reduced 3.27%
2,133,007 $59.2 Million
Q4 2023

Feb 14, 2024

SELL
$26.13 - $33.94 $24.2 Million - $31.4 Million
-925,357 Reduced 29.56%
2,205,050 $63.5 Million
Q2 2023

Aug 15, 2023

BUY
$36.12 - $41.79 $53.5 Million - $61.9 Million
1,480,834 Added 89.77%
3,130,407 $115 Million
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $14.8 Million - $19.3 Million
-375,934 Reduced 18.56%
1,649,573 $67.3 Million
Q4 2022

Feb 15, 2023

SELL
$41.75 - $54.5 $7.58 Million - $9.9 Million
-181,598 Reduced 8.23%
2,025,507 $104 Million
Q2 2022

Aug 15, 2022

SELL
$46.53 - $55.17 $7.4 Million - $8.77 Million
-159,053 Reduced 6.72%
2,207,105 $116 Million
Q1 2022

May 11, 2022

BUY
$45.75 - $56.69 $21.9 Million - $27.1 Million
478,827 Added 25.37%
2,366,158 $122 Million
Q4 2021

Feb 15, 2022

SELL
$41.32 - $61.25 $7.61 Million - $11.3 Million
-184,094 Reduced 8.89%
1,887,331 $111 Million
Q3 2021

Nov 12, 2021

BUY
$39.25 - $50.42 $28.7 Million - $36.8 Million
730,658 Added 54.5%
2,071,425 $89.1 Million
Q2 2021

Aug 11, 2021

BUY
$35.91 - $40.68 $7.72 Million - $8.75 Million
215,017 Added 19.1%
1,340,767 $52.5 Million
Q1 2021

May 10, 2021

SELL
$33.49 - $37.77 $51.4 Million - $57.9 Million
-1,533,536 Reduced 57.67%
1,125,750 $40.8 Million
Q4 2020

Feb 09, 2021

BUY
$33.47 - $42.56 $48.1 Million - $61.2 Million
1,437,207 Added 117.6%
2,659,286 $97.9 Million
Q3 2020

Nov 16, 2020

SELL
$31.75 - $37.25 $2.45 Million - $2.88 Million
-77,304 Reduced 5.95%
1,222,079 $44.9 Million
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $21.1 Million - $25.6 Million
-701,750 Reduced 35.07%
1,299,383 $42.5 Million
Q1 2020

May 15, 2020

BUY
$27.03 - $38.62 $4.33 Million - $6.19 Million
160,203 Added 8.7%
2,001,133 $65.3 Million
Q4 2019

Feb 06, 2020

SELL
$32.92 - $37.36 $45.5 Million - $51.6 Million
-1,380,997 Reduced 42.86%
1,840,930 $72.1 Million
Q3 2019

Oct 30, 2019

BUY
$32.49 - $42.13 $36.1 Million - $46.8 Million
1,111,987 Added 52.7%
3,221,927 $116 Million
Q2 2019

Aug 12, 2019

SELL
$36.98 - $41.52 $18.7 Million - $21 Million
-506,420 Reduced 19.36%
2,109,940 $91.4 Million
Q1 2019

May 13, 2019

BUY
$37.5 - $41.2 $1.39 Million - $1.53 Million
37,034 Added 1.44%
2,616,360 $111 Million
Q4 2018

Feb 11, 2019

SELL
$38.47 - $43.86 $52.2 Million - $59.5 Million
-1,355,759 Reduced 34.45%
2,579,326 $113 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $56.8 Million - $68.9 Million
1,648,987 Added 72.13%
3,935,085 $173 Million
Q2 2018

Aug 14, 2018

SELL
$32.98 - $35.16 $40 Million - $42.7 Million
-1,213,080 Reduced 34.67%
2,286,098 $82.9 Million
Q1 2018

May 11, 2018

SELL
$31.91 - $37.02 $28.1 Million - $32.6 Million
-881,707 Reduced 20.13%
3,499,178 $124 Million
Q4 2017

Feb 12, 2018

BUY
$33.26 - $35.29 $20.9 Million - $22.2 Million
629,141 Added 16.77%
4,380,885 $159 Million
Q3 2017

Nov 01, 2017

BUY
$31.0 - $34.15 $116 Million - $128 Million
3,751,744
3,751,744 $134 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track State Of Tennessee, Treasury Department Portfolio

Follow State Of Tennessee, Treasury Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Tennessee, Treasury Department, based on Form 13F filings with the SEC.

News

Stay updated on State Of Tennessee, Treasury Department with notifications on news.